{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T02:58:30Z","timestamp":1784602710398,"version":"3.55.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T00:00:00Z","timestamp":1693958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T00:00:00Z","timestamp":1693958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s11910-023-01294-y","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T03:29:56Z","timestamp":1693970996000},"page":"617-625","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Sleep Disturbances in Autoimmune Neurological Diseases"],"prefix":"10.1007","volume":"23","author":[{"given":"Laura","family":"P\u00e9rez-Carbonell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Iranzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,6]]},"reference":[{"issue":"10","key":"1294_CR1","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.3389\/fimmu.2019.01827","volume":"6","author":"MR Zielinski","year":"2019","unstructured":"Zielinski MR, Systrom DM, Rose NR. Fatigue, sleep, and autoimmune and related disorders. Front Immunol. 2019;6(10):1827.","journal-title":"Front Immunol."},{"issue":"1","key":"1294_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11940-019-0544-7","volume":"21","author":"GK Sakkas","year":"2019","unstructured":"Sakkas GK, Giannaki CD, Karatzaferi C, Manconi M. Sleep abnormalities in multiple sclerosis. Curr Treat Options Neurol. 2019;21(1):4.","journal-title":"Curr Treat Options Neurol."},{"issue":"1","key":"1294_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41386-019-0463-z","volume":"45","author":"A Iranzo","year":"2020","unstructured":"Iranzo A. Sleep and neurological autoimmune diseases. Neuropsychopharmacol. 2020;45(1):129\u201340.","journal-title":"Neuropsychopharmacol."},{"issue":"4","key":"1294_CR4","first-page":"988","volume":"28","author":"M Ward","year":"2022","unstructured":"Ward M, Goldman MD. Epidemiology and pathophysiology of multiple sclerosis. CONTINUUM: Lifelong Learning in Neurology. 2022;28(4):988\u20131005.","journal-title":"CONTINUUM: Lifelong Learning in Neurology."},{"key":"1294_CR5","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.smrv.2018.03.007","volume":"41","author":"G Morris","year":"2018","unstructured":"Morris G, Stubbs B, K\u00f6hler CA, Walder K, Slyepchenko A, Berk M, et al. The putative role of oxidative stress and inflammation in the pathophysiology of sleep dysfunction across neuropsychiatric disorders: focus on chronic fatigue syndrome, bipolar disorder and multiple sclerosis. Sleep Med Rev. 2018;41:255\u201365.","journal-title":"Sleep Med Rev."},{"issue":"4","key":"1294_CR6","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1191\/135248506ms1320oa","volume":"12","author":"BR Stanton","year":"2006","unstructured":"Stanton BR, Barnes F, Silber E. Sleep and fatigue in multiple sclerosis. Mult Scler. 2006;12(4):481\u20136.","journal-title":"Mult Scler."},{"key":"1294_CR7","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.sleep.2019.01.010","volume":"56","author":"M Foschi","year":"2019","unstructured":"Foschi M, Rizzo G, Liguori R, Avoni P, Mancinelli L, Lugaresi A, et al. Sleep-related disorders and their relationship with MRI findings in multiple sclerosis. Sleep Med. 2019;56:90\u20137.","journal-title":"Sleep Med."},{"issue":"8","key":"1294_CR8","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1177\/1352458511432328","volume":"18","author":"M Kaminska","year":"2012","unstructured":"Kaminska M, Kimoff R, Benedetti A, Robinson A, Bar-Or A, Lapierre Y, et al. Obstructive sleep apnea is associated with fatigue in multiple sclerosis. Mult Scler. 2012;18(8):1159\u201369.","journal-title":"Mult Scler."},{"key":"1294_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.smrv.2014.10.002","volume":"22","author":"M Sieminski","year":"2015","unstructured":"Sieminski M, Losy J, Partinen M. Restless legs syndrome in multiple sclerosis. Sleep Med Rev. 2015;22:15\u201322.","journal-title":"Sleep Med Rev."},{"issue":"10","key":"1294_CR10","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1212\/01.wnl.0000184519.47689.c4","volume":"65","author":"C Auger","year":"2005","unstructured":"Auger C, Montplaisir J, Duquette P. Increased frequency of restless legs syndrome in a French-Canadian population with multiple sclerosis. Neurology. 2005;65(10):1652\u20133.","journal-title":"Neurology."},{"issue":"6","key":"1294_CR11","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1177\/1352458506074644","volume":"13","author":"MJ G\u00f3mez-Choco","year":"2007","unstructured":"G\u00f3mez-Choco MJ, Iranzo A, Blanco Y, Graus F, Santamaria J, Saiz A. Prevalence of restless legs syndrome and REM sleep behavior disorder in multiple sclerosis. Mult Scler. 2007;13(6):805\u20138.","journal-title":"Mult Scler."},{"key":"1294_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.sleep.2019.11.1266","volume":"70","author":"V Shaygannejad","year":"2020","unstructured":"Shaygannejad V, Sadeghi Bahmani D, Soleimani P, Mirmosayyeb O, Barzegar M, Amra B, et al. Comparison of prevalence rates of restless legs syndrome, self-assessed risks of obstructive sleep apnea, and daytime sleepiness among patients with multiple sclerosis (MS), clinically isolated syndrome (CIS) and Neuromyelitis Optica Spectrum Disorder (NMOSD). Sleep Med. 2020;70:97\u2013105.","journal-title":"Sleep Med."},{"issue":"2","key":"1294_CR13","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/0022-510X(94)90035-3","volume":"125","author":"L Ferini-Strambi","year":"1994","unstructured":"Ferini-Strambi L, Filippi M, Martinelli V, Oldani A, Rovaris M, Zucconi M, et al. Nocturnal sleep study in multiple sclerosis: correlations with clinical and brain magnetic resonance imaging findings. J Neurol Sci. 1994;125(2):194\u20137.","journal-title":"J Neurol Sci."},{"key":"1294_CR14","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1001\/archneurol.2009.264","volume":"66","author":"T Kanbayashi","year":"2009","unstructured":"Kanbayashi T, Shimohata T, Nakashima I, Yaguchi H, Yabe I, Nishizawa M, et al. Symptomatic narcolepsy in patients with neuromyelitis optica and multiple sclerosis: new neurochemical and immunological implications. Arch Neurol. 2009;66:1563\u20136. Available from: http:\/\/archneur.jamanetwork.com\/article.aspx?doi=10.1001\/archneurol.2009.264","journal-title":"Arch Neurol"},{"issue":"9","key":"1294_CR15","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1007\/s00415-018-8949-x","volume":"265","author":"U Kallweit","year":"2018","unstructured":"Kallweit U, Bassetti CLA, Oberholzer M, Fronczek R, B\u00e9guin M, Strub M, et al. Coexisting narcolepsy (with and without cataplexy) and multiple sclerosis: six new cases and a literature review. J Neurol. 2018;265(9):2071\u20138.","journal-title":"J Neurol."},{"issue":"8","key":"1294_CR16","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1212\/01.wnl.0000208518.72660.ff","volume":"66","author":"M Tippmann-Peikert","year":"2006","unstructured":"Tippmann-Peikert M, Boeve BF, Keegan BM. REM sleep behavior disorder initiated by acute brainstem multiple sclerosis. Neurology. 2006;66(8):1277\u20139.","journal-title":"Neurology."},{"issue":"9451","key":"1294_CR17","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. The Lancet. 2004;364(9451):2106\u201312.","journal-title":"The Lancet."},{"issue":"2","key":"1294_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177\u201389.","journal-title":"Neurology."},{"issue":"1\u20132","key":"1294_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jns.2011.08.031","volume":"312","author":"K Deguchi","year":"2012","unstructured":"Deguchi K, Kono S, Deguchi S, Morimoto N, Ikeda M, Kurata T, et al. A patient with anti-aquaporin 4 antibody presenting hypersomnolence as the initial symptom and symmetrical hypothalamic lesions. J Neurol Sci. 2012;312(1\u20132):18\u201320.","journal-title":"J Neurol Sci."},{"key":"1294_CR20","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1001\/archneurol.2012.300","volume":"69","author":"K Suzuki","year":"2012","unstructured":"Suzuki K, Nakamura T, Hashimoto K, Miyamoto M, Komagamine T, Nagashima T, et al. Hypothermia, hypotension, hypersomnia, and obesity associated with hypothalamic lesions in a patient positive for the anti\u2013aquaporin 4 antibody: a case report and literature review. Arch Neurol. 2012;69:1355\u20139. Available from: http:\/\/archneur.jamanetwork.com\/article.aspx?doi=10.1001\/archneurol.2012.300","journal-title":"Arch Neurol"},{"issue":"2","key":"1294_CR21","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.sleep.2007.11.022","volume":"10","author":"H Nozaki","year":"2009","unstructured":"Nozaki H, Shimohata T, Kanbayashi T, Sagawa Y, Katada S, Satoh M, et al. A patient with anti-aquaporin 4 antibody who presented with recurrent hypersomnia, reduced orexin (hypocretin) level, and symmetrical hypothalamic lesions. Sleep Med. 2009;10(2):253\u20135.","journal-title":"Sleep Med."},{"issue":"1\u20132","key":"1294_CR22","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jns.2014.08.041","volume":"346","author":"C\u0130 K\u00fc\u00e7\u00fckali","year":"2014","unstructured":"K\u00fc\u00e7\u00fckali C\u0130, Haytural H, Benbir G, \u00c7oban A, Ulusoy C, Giri\u015f M, et al. Reduced serum orexin-A levels in autoimmune encephalitis and neuromyelitis optica patients. J Neurol Sci. 2014;346(1\u20132):353\u20135.","journal-title":"J Neurol Sci."},{"issue":"6","key":"1294_CR23","doi-asserted-by":"publisher","first-page":"e671","DOI":"10.1212\/WNL.0000000000009987","volume":"95","author":"H Ari\u00f1o","year":"2020","unstructured":"\u2022\u2022 Ari\u00f1o H, Mu\u00f1oz-Lopetegi A, Martinez-Hernandez E, Armangue T, Rosa-Justicia M, Escudero D, et al. Sleep disorders in anti-NMDAR encephalitis. Neurology. 2020;95(6):e671\u201384. Excellent prospective study including an objective assessment of sleep with video-polysomnography in patients with previous diagnosis of anti-NMDA receptor encephalitis.","journal-title":"Neurology"},{"issue":"12","key":"1294_CR24","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/S1474-4422(20)30341-0","volume":"19","author":"A Mu\u00f1oz-Lopetegi","year":"2020","unstructured":"\u2022 Mu\u00f1oz-Lopetegi A, Graus F, Dalmau J, Santamaria J. Sleep disorders in autoimmune encephalitis. Lancet Neurol. 2020;19(12):1010\u201322. Exhaustive review of the sleep symptoms and disorders in the context of autoimmune encephalitis reported in the scientific literature.","journal-title":"Lancet Neurol."},{"issue":"14","key":"1294_CR25","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1212\/WNL.0000000000003173","volume":"87","author":"A Van Sonderen","year":"2016","unstructured":"Van Sonderen A, Thijs RD, Coenders EC, Jiskoot LC, Sanchez E, De Bruijn MAAM, et al. Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up. Neurology. 2016;87(14):1449\u201356.","journal-title":"Neurology."},{"issue":"8","key":"1294_CR26","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1212\/WNL.0000000000003009","volume":"87","author":"H Ari\u00f1o","year":"2016","unstructured":"Ari\u00f1o H, Armangu\u00e9 T, Petit-Pedrol M, Sabater L, Martinez-Hernandez E, Hara M, et al. Anti-LGI1\u2013associated cognitive impairment: presentation and long-term outcome. Neurology. 2016;87(8):759\u201365.","journal-title":"Neurology."},{"issue":"1","key":"1294_CR27","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/ana.20693","volume":"59","author":"A Iranzo","year":"2006","unstructured":"Iranzo A, Graus F, Clover L, Morera J, Bruna J, Vilar C, et al. Rapid eye movement sleep behavior disorder and potassium channel antibody-associated limbic encephalitis. Ann Neurol. 2006;59(1):178\u201381.","journal-title":"Ann Neurol."},{"issue":"10","key":"1294_CR28","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.sleep.2011.05.005","volume":"12","author":"F Provini","year":"2011","unstructured":"Provini F, Marconi S, Amadori M, Guaraldi P, Pierangeli G, Cortelli P, et al. Morvan chorea and agrypnia excitata: when video-polysomnographic recording guides the diagnosis. Sleep Med. 2011;12(10):1041\u20133.","journal-title":"Sleep Med."},{"issue":"7","key":"1294_CR29","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.sleep.2015.03.017","volume":"16","author":"G Abgrall","year":"2015","unstructured":"Abgrall G, Demeret S, Rohaut B, Leu-Semenescu S, Arnulf I. Status dissociatus and disturbed dreaming in a patient with Morvan syndrome plus myasthenia gravis. Sleep Med. 2015;16(7):894\u20136.","journal-title":"Sleep Med."},{"issue":"20","key":"1294_CR30","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1212\/WNL.0000000000000991","volume":"83","author":"WO Tobin","year":"2014","unstructured":"Tobin WO, Lennon VA, Komorowski L, Probst C, Clardy SL, Aksamit AJ, et al. DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients. Neurology. 2014;83(20):1797\u2013803.","journal-title":"Neurology."},{"issue":"6","key":"1294_CR31","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/sleep\/30.6.767","volume":"30","author":"Y Compta","year":"2007","unstructured":"Compta Y, Iranzo A, Santamar\u00eda J, Casamitjana R, Graus F. REM sleep behavior disorder and narcoleptic features in anti\u2014Ma2-associated encephalitis. Sleep. 2007;30(6):767\u20139.","journal-title":"Sleep."},{"issue":"10","key":"1294_CR32","first-page":"1305","volume":"70","author":"Y Dauvilliers","year":"2013","unstructured":"Dauvilliers Y, Bauer J, Rigau V, Lalloyer N, Labauge P, Carlander B, et al. Hypothalamic immunopathology in anti-Ma\u2013associated diencephalitis with narcolepsy-cataplexy. JAMA Neurol. 2013;70(10):1305\u201310. Available from: http:\/\/archneur.jamanetwork.com\/article.aspx?doi=10.1001\/jamaneurol.2013.2831","journal-title":"JAMA Neurol"},{"issue":"1","key":"1294_CR33","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1212\/01.WNL.0000101718.92619.67","volume":"62","author":"S Overeem","year":"2004","unstructured":"Overeem S, Dalmau J, Bataller L, Nishino S, Mignot E, Verschuuren J, et al. Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis. Neurology. 2004;62(1):138\u201340.","journal-title":"Neurology."},{"issue":"4","key":"1294_CR34","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/jnnp.2008.158246","volume":"80","author":"A Saiz","year":"2008","unstructured":"Saiz A, Bruna J, Stourac P, Vigliani MC, Giometto B, Grisold W, et al. Anti-Hu-associated brainstem encephalitis. J Neurol Neurosurg Psychiatry. 2008;80(4):404\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10280","key":"1294_CR35","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","volume":"397","author":"N Shahrizaila","year":"2021","unstructured":"Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barr\u00e9 syndrome. The Lancet. 2021;397(10280):1214\u201328.","journal-title":"The Lancet."},{"issue":"2","key":"1294_CR36","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/j.1600-0404.2012.01688.x","volume":"127","author":"K Karkare","year":"2013","unstructured":"Karkare K, Sinha S, Taly AB, Rao S. Prevalence and profile of sleep disturbances in Guillain-Barre syndrome: a prospective questionnaire-based study during 10 days of hospitalization. Acta Neurol Scand. 2013;127(2):116\u201323.","journal-title":"Acta Neurol Scand."},{"issue":"10","key":"1294_CR37","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3109\/00207454.2015.1080699","volume":"126","author":"J Gao","year":"2016","unstructured":"Gao J, Li Y, Sun Y, Hu W, Liu Y, An D, et al. The study of sleep disorder factors in patients with Guillain\u2013Barr\u00e9 syndrome. Int J Neurosci. 2016;126(10):893\u20138.","journal-title":"Int J Neurosci."},{"issue":"1","key":"1294_CR38","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41983-018-0007-1","volume":"54","author":"WS Bahnasy","year":"2018","unstructured":"Bahnasy WS, El-Heneedy YAE, El-Shamy AM, Badr MY, Amer RA, Ibrahim ISE. Sleep and psychiatric abnormalities in Gullian Barr\u00e9 syndrome. Egypt J Neurol Psychiatry Neurosurg. 2018;54(1):5.","journal-title":"Egypt J Neurol Psychiatry Neurosurg."},{"issue":"2","key":"1294_CR39","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/sleep\/9.2.293","volume":"9","author":"CH Schenck","year":"1986","unstructured":"Schenck CH, Bundlie SR, Ettinger MG, Mahowald MW. Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep. 1986;9(2):293\u2013308.","journal-title":"Sleep."},{"issue":"11","key":"1294_CR40","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1093\/brain\/awh585","volume":"128","author":"V Cochen","year":"2005","unstructured":"Cochen V, Arnulf I, Demeret S, Neulat ML, Gourlet V, Drouot X, et al. Vivid dreams, hallucinations, psychosis and REM sleep in Guillain\u2013Barr\u00e9 syndrome. Brain. 2005;128(11):2535\u201345.","journal-title":"Brain."},{"key":"1294_CR41","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1016\/j.sleep.2011.10.011","volume":"12","author":"R Manni","year":"2011","unstructured":"Manni R, Ratti PL, Terzaghi M. Secondary \u2018\u201cincidental\u201d\u2019 REM sleep behavior disorder: do we ever think of it? Sleep Med. 2011;12:S50\u20133.","journal-title":"Sleep Med."},{"issue":"8","key":"1294_CR42","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/S1474-4422(19)30144-9","volume":"18","author":"C Bunschoten","year":"2019","unstructured":"Bunschoten C, Jacobs BC, Van Den Bergh PYK, Cornblath DR, Van Doorn PA. Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy. The Lancet Neurology. 2019;18(8):784\u201394.","journal-title":"The Lancet Neurology."},{"issue":"3","key":"1294_CR43","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1590\/0004-282X20130232","volume":"72","author":"PL Santos","year":"2014","unstructured":"Santos PL, Almeida-Ribeiro GA, Silva DMD, Marques Junior W, Barreira AA. Chronic inflammatory demyelinating polyneuropathy: quality of life, sociodemographic profile and physical complaints. Arq Neuro-Psiquiatr. 2014;72(3):179\u201383.","journal-title":"Arq Neuro-Psiquiatr."},{"issue":"2","key":"1294_CR44","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/mus.21684","volume":"42","author":"YA Rajabally","year":"2010","unstructured":"Rajabally YA, Shah RS. Restless legs syndrome in chronic inflammatory demyelinating polyneuropathy: restless legs syndrome in CIDP. Muscle Nerve. 2010;42(2):252\u20136.","journal-title":"Muscle Nerve."},{"key":"1294_CR45","doi-asserted-by":"publisher","first-page":"945","DOI":"10.5664\/jcsm.3000","volume":"09","author":"M Luigetti","year":"2013","unstructured":"Luigetti M, Del Grande A, Testani E, Bisogni G, Losurdo A, Giannantoni NM, et al. Restless leg syndrome in different types of demyelinating neuropathies: a single-center pilot study. J Clin Sleep Med. 2013;09:945\u20139.","journal-title":"J Clin Sleep Med."},{"issue":"2","key":"1294_CR46","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/mus.23296","volume":"46","author":"EH Mart\u00ednez-Lapiscina","year":"2012","unstructured":"Mart\u00ednez-Lapiscina EH, Erro ME, Ayuso T, Jeric\u00f3 I. Myasthenia gravis: sleep quality, quality of life, and disease severity. Muscle Nerve. 2012;46(2):174\u201380.","journal-title":"Muscle Nerve."},{"issue":"1","key":"1294_CR47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s13760-017-0787-6","volume":"118","author":"NF Tascilar","year":"2018","unstructured":"Tascilar NF, Saracli O, Kurcer MA, Ankarali H, Emre U. Is there any relationship between quality of life and polysomnographically detected sleep parameters\/disorders in stable myasthenia gravis? Acta Neurol Belg. 2018;118(1):29\u201337.","journal-title":"Acta Neurol Belg."},{"issue":"1","key":"1294_CR48","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1212\/01.wnl.0000223515.15691.26","volume":"67","author":"MW Nicolle","year":"2006","unstructured":"Nicolle MW, Rask S, Koopman WJ, George CFP, Adams J, Wiebe S. Sleep apnea in patients with myasthenia gravis. Neurology. 2006;67(1):140\u20132.","journal-title":"Neurology."},{"issue":"3","key":"1294_CR49","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/ane.12382","volume":"132","author":"JH Yeh","year":"2015","unstructured":"Yeh JH, Lin CM, Chiu HC, Bai CH. Home sleep study for patients with myasthenia gravis. Acta Neurol Scand. 2015;132(3):191\u20135.","journal-title":"Acta Neurol Scand."},{"issue":"3","key":"1294_CR50","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1159\/000339485","volume":"68","author":"M Sieminski","year":"2012","unstructured":"Sieminski M, Bili\u0144ska M, Nyka WM. Increased frequency of restless legs syndrome in myasthenia gravis. Eur Neurol. 2012;68(3):166\u201370.","journal-title":"Eur Neurol."},{"issue":"2","key":"1294_CR51","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/mus.21204","volume":"39","author":"A Selva-O\u2019Callaghan","year":"2009","unstructured":"Selva-O\u2019Callaghan A, Sampol G, Romero O, Lloberes P, Trallero-Aragu\u00e1s E, Vilardell-Tarr\u00e9s M. Obstructive sleep apnea in patients with inflammatory myopathies. Muscle Nerve. 2009;39(2):144\u20139.","journal-title":"Muscle Nerve."},{"issue":"8","key":"1294_CR52","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1016\/j.clinph.2013.03.002","volume":"124","author":"G Della Marca","year":"2013","unstructured":"Della Marca G, Sancricca C, Losurdo A, Di Blasi C, De Fino C, Morosetti R, et al. Sleep disordered breathing in a cohort of patients with sporadic inclusion body myositis. Clin Neurophysiol. 2013;124(8):1615\u201321.","journal-title":"Clin Neurophysiol."},{"issue":"12","key":"1294_CR53","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.nmd.2014.08.003","volume":"24","author":"PM Rodr\u00edguez Cruz","year":"2014","unstructured":"Rodr\u00edguez Cruz PM, Needham M, Hollingsworth P, Mastaglia FL, Hillman DR. Sleep disordered breathing and subclinical impairment of respiratory function are common in sporadic inclusion body myositis. Neuromuscul Disord. 2014;24(12):1036\u201341.","journal-title":"Neuromuscul Disord."},{"issue":"9560","key":"1294_CR54","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0140-6736(07)60237-2","volume":"369","author":"Y Dauvilliers","year":"2007","unstructured":"Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. The Lancet. 2007;369(9560):499\u2013511.","journal-title":"The Lancet."},{"issue":"11","key":"1294_CR55","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1212\/WNL.57.11.2029","volume":"57","author":"Y Dauvilliers","year":"2001","unstructured":"Dauvilliers Y, Montplaisir J, Molinari N, Carlander B, Ondze B, Besset A, et al. Age at onset of narcolepsy in two large populations of patients in France and Quebec. Neurology. 2001;57(11):2029\u201333.","journal-title":"Neurology."},{"issue":"10357","key":"1294_CR56","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(22)01018-2","volume":"400","author":"L P\u00e9rez-Carbonell","year":"2022","unstructured":"\u2022\u2022 P\u00e9rez-Carbonell L, Mignot E, Leschziner G. Dauvilliers Y. Understanding and approaching excessive daytime sleepiness. Lancet. 2022;400(10357):1033\u201346. Thorough review that highlights the importance of a correct differential diagnosis and assessment when excessive daytime sleepiness is reported.","journal-title":"Lancet."},{"key":"1294_CR57","doi-asserted-by":"publisher","first-page":"101683","DOI":"10.1016\/j.smrv.2022.101683","volume":"65","author":"S Melzi","year":"2022","unstructured":"\u2022 Melzi S, Prevot V, Peyron C. Precocious puberty in narcolepsy type 1: orexin loss and\/or neuroinflammation, which is to blame? Sleep Med Rev. 2022;65:101683. Comprehensive review of the narcolepsy type 1 pathogenesis with emphasis in the role of neuroinflammation and endocrine features.","journal-title":"Sleep Med Rev."},{"issue":"1","key":"1294_CR58","doi-asserted-by":"publisher","first-page":"19","DOI":"10.5665\/sleep.3300","volume":"37","author":"M Tafti","year":"2014","unstructured":"Behalf of the European Narcolepsy Network (EU-NN), Tafti M, Hor H, Dauvilliers Y, Lammers GJ, Overeem S, et al. DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe. Sleep. 2014;37(1):19\u201325.","journal-title":"Sleep."},{"issue":"11","key":"1294_CR59","doi-asserted-by":"publisher","first-page":"zsaa099","DOI":"10.1093\/sleep\/zsaa099","volume":"43","author":"HM Ollila","year":"2020","unstructured":"Ollila HM. Narcolepsy type 1: what have we learned from genetics? Sleep. 2020;43(11):zsaa099.","journal-title":"Sleep."},{"issue":"7725","key":"1294_CR60","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41586-018-0540-1","volume":"562","author":"D Latorre","year":"2018","unstructured":"Latorre D, Kallweit U, Armentani E, Foglierini M, Mele F, Cassotta A, et al. T cells in patients with narcolepsy target self-antigens of hypocretin neurons. Nature. 2018;562(7725):63\u20138.","journal-title":"Nature."},{"issue":"1","key":"1294_CR61","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/s41467-019-08774-1","volume":"10","author":"NW Pedersen","year":"2019","unstructured":"Pedersen NW, Holm A, Kristensen NP, Bjerregaard AM, Bentzen AK, Marquard AM, et al. CD8+ T cells from patients with narcolepsy and healthy controls recognize hypocretin neuron-specific antigens. Nat Commun. 2019;10(1):837.","journal-title":"Nat Commun."},{"issue":"6","key":"1294_CR62","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/S1474-4422(14)70075-4","volume":"13","author":"M Partinen","year":"2014","unstructured":"Partinen M, Kornum BR, Plazzi G, Jennum P, Julkunen I, Vaarala O. Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination. Lancet Neurol. 2014 Jun;13(6):600\u201313.","journal-title":"Lancet Neurol."},{"key":"1294_CR63","first-page":"387","volume-title":"Sleep medicine textbook","author":"CLA Bassetti","year":"2021","unstructured":"Bassetti CLA, Lammers GJ. Hypersomnias of central origin. Etio-pathophysiology. In: Sleep medicine textbook. 2nd ed. Regensburg: European Sleep Research Society (ESRS); 2021. p. 387\u2013400.","edition":"2"},{"key":"1294_CR64","volume-title":"The International Classification of Sleep Disorders - Third Edition (ICSD-3)","author":"American Academy of Sleep Medicine","year":"2014","unstructured":"American Academy of Sleep Medicine. The International Classification of Sleep Disorders - Third Edition (ICSD-3). Darien, IL: American Academy of Sleep Medicine; 2014."},{"key":"1294_CR65","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.2147\/NSS.S359980","volume":"14","author":"Z Zhang","year":"2022","unstructured":"\u2022\u2022 Zhang Z, Dauvilliers Y, Plazzi G, Mayer G, Lammers GJ, Santamaria J, et al. Idling for decades: a European study on risk factors associated with the delay before a narcolepsy diagnosis. NSS. 2022;14:1031\u201347. European study that brings out the ongoing issue of diagnosis delay in narcolepsy type 1 and the need for strategies to increase awareness and to improve the detection of this condition.","journal-title":"NSS."},{"issue":"11","key":"1294_CR66","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11940-019-0595-9","volume":"21","author":"L P\u00e9rez-Carbonell","year":"2019","unstructured":"P\u00e9rez-Carbonell L. Treatment of excessive daytime sleepiness in patients with narcolepsy. Curr Treat Options Neurol. 2019;21(11):57.","journal-title":"Curr Treat Options Neurol."},{"issue":"5","key":"1294_CR67","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1001\/archneur.61.5.758","volume":"61","author":"RF Gledhill","year":"2004","unstructured":"Gledhill RF, Bartel PR, Yoshida Y, Nishino S, Scammell TE. Narcolepsy caused by acute disseminated encephalomyelitis. Arch Neurol. 2004;61(5):758.","journal-title":"Arch Neurol."},{"issue":"09","key":"1294_CR68","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.5664\/jcsm.5028","volume":"11","author":"MC Mayo","year":"2015","unstructured":"Mayo MC, Deng JC, Albores J, Zeidler M, Harper RM, Avidan AY. Hypocretin deficiency associated with narcolepsy type 1 and central hypoventilation syndrome in neurosarcoidosis of the hypothalamus. J Clin Sleep Med. 2015;11(09):1063\u20135.","journal-title":"J Clin Sleep Med."},{"issue":"18","key":"1294_CR69","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1212\/WNL.0000000000003887","volume":"88","author":"C Gaig","year":"2017","unstructured":"Gaig C, Graus F, Compta Y, H\u00f6gl B, Bataller L, Br\u00fcggemann N, et al. Clinical manifestations of the anti-IgLON5 disease. Neurology. 2017;88(18):1736\u201343.","journal-title":"Neurology."},{"issue":"6","key":"1294_CR70","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","volume":"13","author":"L Sabater","year":"2014","unstructured":"Sabater L, Gaig C, Gelpi E, Bataller L, Lewerenz J, Torres-Vega E, et al. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol. 2014;13(6):575\u201386.","journal-title":"Lancet Neurol."},{"issue":"9","key":"1294_CR71","doi-asserted-by":"publisher","first-page":"zsz133","DOI":"10.1093\/sleep\/zsz133","volume":"42","author":"C Gaig","year":"2019","unstructured":"Gaig C, Iranzo A, Cajochen C, Vilaseca I, Embid C, Dalmau J, et al. Characterization of the sleep disorder of anti-IgLON5 disease. Sleep. 2019;42(9):zsz133.","journal-title":"Sleep."},{"issue":"7","key":"1294_CR72","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11910-018-0848-0","volume":"18","author":"C Gaig","year":"2018","unstructured":"Gaig C, Iranzo A, Santamaria J, Graus F. The sleep disorder in anti-lgLON5 disease. Curr Neurol Neurosci Rep. 2018;18(7):41.","journal-title":"Curr Neurol Neurosci Rep."},{"issue":"5","key":"1294_CR73","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1002\/ana.25857","volume":"88","author":"J Landa","year":"2020","unstructured":"Landa J, Gaig C, Plagum\u00e0 J, Saiz A, Antonell A, Sanchez-Valle R, et al. Effects of IgLON5 antibodies on neuronal cytoskeleton: a link between autoimmunity and neurodegeneration. Ann Neurol. 2020;88(5):1023\u20137.","journal-title":"Ann Neurol."},{"issue":"4","key":"1294_CR74","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00401-016-1591-8","volume":"132","author":"E Gelpi","year":"2016","unstructured":"Gelpi E, H\u00f6ftberger R, Graus F, Ling H, Holton JL, Dawson T, et al. Neuropathological criteria of anti-IgLON5-related tauopathy. Acta Neuropathol. 2016;132(4):531\u201343.","journal-title":"Acta Neuropathol."},{"issue":"4","key":"1294_CR75","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/ane.13207","volume":"141","author":"P Cabezudo-Garc\u00eda","year":"2020","unstructured":"Cabezudo-Garc\u00eda P, Mena-V\u00e1zquez N, Estivill Torr\u00fas G, Serrano-Castro P. Response to immunotherapy in anti-IgLON5 disease: a systematic review. Acta Neurol Scand. 2020;141(4):263\u201370.","journal-title":"Acta Neurol Scand."},{"issue":"7","key":"1294_CR76","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1007\/s00415-020-09924-y","volume":"267","author":"T Gr\u00fcter","year":"2020","unstructured":"Gr\u00fcter T, Behrendt V, Bien CI, Gold R, Ayzenberg I. Early immunotherapy is highly effective in IgG1\/IgG4 positive IgLON5 disease. J Neurol. 2020;267(7):2151\u20133.","journal-title":"J Neurol."},{"issue":"4","key":"1294_CR77","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/ana.21333","volume":"63","author":"I Arnulf","year":"2008","unstructured":"Arnulf I, Lin L, Gadoth N, File J, Lecendreux M, Franco P, et al. Kleine-Levin syndrome: a systematic study of 108 patients. Ann Neurol. 2008;63(4):482\u201393.","journal-title":"Ann Neurol."},{"issue":"10","key":"1294_CR78","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/S1474-4422(12)70187-4","volume":"11","author":"I Arnulf","year":"2012","unstructured":"Arnulf I, Rico TJ, Mignot E. Diagnosis, disease course, and management of patients with Kleine-Levin syndrome. Lancet Neurol. 2012;11(10):918\u201328.","journal-title":"Lancet Neurol."},{"issue":"11","key":"1294_CR79","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1212\/01.WNL.0000036605.89977.D0","volume":"59","author":"Y Dauvilliers","year":"2002","unstructured":"Dauvilliers Y, Mayer G, Lecendreux M, Neidhart E, Peraita-Adrados R, Sonka K, et al. Kleine-Levin syndrome: an autoimmune hypothesis based on clinical and genetic analyses. Neurology. 2002;59(11):1739\u201345.","journal-title":"Neurology."},{"issue":"12","key":"1294_CR80","doi-asserted-by":"publisher","first-page":"e2005753118","DOI":"10.1073\/pnas.2005753118","volume":"118","author":"A Ambati","year":"2021","unstructured":"Ambati A, Hillary R, Leu-Semenescu S, Ollila HM, Lin L, During EH, et al. Kleine-Levin syndrome is associated with birth difficulties and genetic variants in the TRANK1 gene loci. Proc Natl Acad Sci USA. 2021;118(12):e2005753118.","journal-title":"Proc Natl Acad Sci USA."},{"issue":"19","key":"1294_CR81","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1212\/WNL.0000000000002104","volume":"85","author":"S Leu-Semenescu","year":"2015","unstructured":"Leu-Semenescu S, Le Corvec T, Groos E, Lavault S, Golmard JL, Arnulf I. Lithium therapy in Kleine-Levin syndrome: An open-label, controlled study in 130 patients. Neurology. 2015;85(19):1655\u201362.","journal-title":"Neurology."}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-023-01294-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-023-01294-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-023-01294-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T09:14:13Z","timestamp":1697879653000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-023-01294-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,6]]},"references-count":81,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1294"],"URL":"https:\/\/doi.org\/10.1007\/s11910-023-01294-y","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,6]]},"assertion":[{"value":"9 August 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"LPC reports personal fees from Jazz Pharmaceuticals, outside the submitted work. AI has nothing to disclose related to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}